Biomea Fusion, Inc. BMEA
Set alert
0.64 USD +0.02 +2.68%
At close · Oct 30
0.65 +0.01 +1.49%
After hours · Oct 30, 7:39 PM ET
0.5901 Day range 0.6489
0.585 52-week range 2.21
- YTD
- -48.43%
- 1 year
- -51.92%
- Open
- 0.63
- Prev close
- 0.6228
- Mkt cap
- 46.35M
- Vol
- 1.11M
- Avg vol
- 2.12M
- EPS
- -0.29
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5901
- High
- 0.6489
- Forward P/E
- -1.21
- Beta
- -0.43
- Short ratio
- 12.98
- Inst. own
- 64.56%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 31, 2024
- 50-d avg
- 7.91
- 200-d avg
- 8.85
- 1y target
- 40.56
2Y chart
Events in this range
- Dec 10, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 10, 2024Rating: D. Boral Capital · Buy → Buy
- Dec 16, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 17, 2024Rating: D. Boral Capital · Buy → Buy
- Dec 18, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 19, 2024Rating: D. Boral Capital · Buy → Buy
Signals (96)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| RSI: Overbought | Aug 24, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 18, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | May 29, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 5 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| SMA: Bearish | Apr 28, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| RSI: Overbought | Apr 17, 2026 | 6 months ago |
| RSI: Overbought | Apr 14, 2026 | 6 months ago |
| SMA: Bullish | Apr 7, 2026 | 6 months ago |
| RSI: Overbought | Apr 7, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 27, 2026 | 7 months ago |
| SMA: Bullish | Mar 26, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Feb 18, 2026 | 8 months ago |
| SMA: Bullish | Feb 17, 2026 | 8 months ago |
| SMA: Bearish | Feb 12, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 10, 2026 | 8 months ago |
| SMA: Bullish | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Jan 28, 2026 | 9 months ago |
| SMA: Bullish | Jan 27, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 23, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 8, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| SMA: Bearish | Jan 6, 2026 | 9 months ago |
| SMA: Bullish | Jan 2, 2026 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 26, 2025 | 10 months ago |
| SMA: Bearish | Dec 23, 2025 | 10 months ago |
| SMA: Bullish | Dec 16, 2025 | 10 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 3, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 2, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| RSI: Oversold | Nov 20, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 19, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 7, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 8, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Oct 6, 2025 | 1 year ago |
| RSI: Overbought | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Aug 26, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 13, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 29, 2025 | 1 year ago |
| SMA: Bearish | Jul 17, 2025 | 1 year ago |
| SMA: Bullish | Jul 16, 2025 | 1 year ago |
| SMA: Bearish | Jul 15, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 11, 2025 | 1 year ago |
| SMA: Bullish | Jul 9, 2025 | 1 year ago |
| SMA: Bearish | Jun 27, 2025 | 1 year ago |
| SMA: Bullish | Jun 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 20, 2025 | 1 year ago |
| SMA: Bearish | Jun 18, 2025 | 1 year ago |
| RSI: Overbought | Jun 4, 2025 | 1 year ago |
| SMA: Bullish | Jun 3, 2025 | 1 year ago |
| MACD: Buy Signal | May 29, 2025 | 1 year ago |
| MACD: Sell Signal | May 8, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 21, 2025 | 1 year ago |
| RSI: Oversold | Apr 14, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| RSI: Oversold | Apr 3, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 1, 2025 | 1 year ago |
| RSI: Oversold | Mar 31, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 14, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| RSI: Oversold | Feb 25, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 24, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 20, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 11, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
| RSI: Oversold | Dec 3, 2024 | 1 year ago |
Key statistics
- Market cap
- 145.32M
- Enterprise value
- 74.90M
- Trailing P/E
- 0.00
- Forward P/E
- -1.21
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.91
- EPS (TTM)
- -4.01
- Beta
- -0.43
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -65.44M
- Total cash
- 87.95M
- Total debt
- 9.57M
- Return on equity
- -104.51%
- Shares outstanding
- 36.24M
- Short % of float
- 44.56%
- 50-day average
- 7.91
- 200-day average
- 8.85
Analyst view
Consensus: buy
Buy
Price target (mean) 40.56 +6241.8% upside
Now 0.6395
- Target (low)
- 11.00
- Target (mean)
- 40.56
- Target (high)
- 128.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
- Strong buy3
- Buy4
- Hold2
- Sell0
- Strong sell0
Next earnings
Jul 31, 2024
Expected Jul 31, 2024. Consensus EPS estimate -0.92933.
Financials — quick view
BMEA Revenue — quarterly 0
BMEA Net income — quarterly -8.33M
BMEA EPS — quarterly -0.12
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 29, 2024 | Sep 1, 2024 | -1.05 | -0.91 | +0.14 | +13.33% |
| Jul 31, 2024 | Jun 1, 2024 | -1.03 | -1.03 | 0.00 | 0.00% |
| Jul 31, 2024 | Jun 1, 2024 | -1.03 | — | — | — |
| May 2, 2024 | Mar 1, 2024 | -1.02 | -1.09 | -0.07 | -6.86% |
| May 2, 2024 | Mar 1, 2024 | -1.02 | — | — | — |
| Apr 1, 2024 | Dec 1, 2023 | -0.85 | -0.98 | -0.13 | -15.29% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | D. Boral Capital | main | Buy | Buy |
| Dec 18, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Dec 17, 2024 | D. Boral Capital | main | Buy | Buy |
| Dec 16, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Dec 10, 2024 | D. Boral Capital | main | Buy | Buy |
| Dec 10, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
About Biomea Fusion, Inc.
Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- biomeafusion.com
News
- Biomea Fusion’s BMF-650 Shows Up to 6.1% Weight Loss in Early GLP-1 Study
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Citizens Reiterates Market Outperform on Biomea Fusion, Maintains $7 Price Target
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- State Street, Fastenal And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $4 Price Target
- Why Enovix Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
- What’s Going On With Biomea Fusion (BMEA) Stock After Hours?
- Biomea Fusion's BMF-650 Shows Up to 6.1% Weight Loss in Early GLP-1 Study
- Biomea Fusion, Inc. (BMEA) Discusses BMF-650 Phase I Topline Results and Potential for Separating GI Side Effects from Weight Loss Transcript
Your note
Sign in to keep a note on BMEA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| A2A PHARMACEUTICALS INC | Beneficial Owner of more than 10% of a Class of Security | Sale | May 31, 2023 | 3,500,000 |
| CHEN BIHUA X. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 29, 2023 | 0 |
| ERDTMANN RAINER M | President | Stock Gift | Dec 28, 2023 | 2,532,820 |
| FRIAS JUAN PABLO | Officer | Stock Award(Grant) | May 30, 2024 | 349 |
| HITCHCOCK MICHAEL J.M. | Director | Purchase | Sep 29, 2024 | 15,000 |
| VALLE FRANCO | Chief Financial Officer | Stock Award(Grant) | Nov 28, 2024 | 42,995 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.99% | 5,431,525 | 21.78M | Sep 29, 2024 |
| Cormorant Asset Management, LP | 9.85% | 3,570,872 | 14.32M | Sep 29, 2024 |
| Blackrock Inc. | 6.34% | 2,296,593 | 9.21M | Sep 29, 2024 |
| Baker Bros. Advisors, LP | 5.82% | 2,108,949 | 8.46M | Sep 29, 2024 |
| Vanguard Group Inc | 3.86% | 1,397,897 | 5.61M | Sep 29, 2024 |
| Millennium Management Llc | 3.80% | 1,378,408 | 5.53M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Growth Company Fund | 4.49% | 1,625,837 | 6.52M | Oct 30, 2024 |
| iShares Russell 2000 ETF | 1.98% | 718,868 | 2.88M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 1.96% | 711,773 | 2.85M | Sep 29, 2024 |
| Fidelity Growth Company K6 Fund | 1.71% | 620,200 | 2.49M | Oct 30, 2024 |
| Fidelity Series Growth Company Fund | 1.44% | 520,427 | 2.09M | Oct 30, 2024 |
| Fidelity Select Portfolios - Biotechnology | 1.08% | 392,129 | 1.57M | Oct 30, 2024 |